A reply to "Comment on: 'Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer"

Author(s):
Veggel, B. van; Langen, A.J. de
Published
2020
Publication type
Article / Letter to editor
Date issued
2020-10-01
Language
English
Publisher
ELSEVIER IRELAND LTD
Is part of
hdl
1887/3279591
doi
10.1016/j.lungcan.2020.07.031